Indian Army Inj Diclofenac, Bupivacaine, Lignocaine, Epinephrine & Anesthetic Injectables Tender 2026 Government of India

Tender Overview

Indian Army (Department Of Military Affairs) invites bids for a broad range of injectable medicines including Diclofenac, Bupivacaine, Lignocaine, Epinephrine, Dexamethasone, Amikacin, Metoclopramide, Ketamine, Propofol, Succinylcholine, Atracurium, Vecuronium, Esmolol, Metoprolol, Dobutamine, Nitroglycerin, Calcium preparations, Sodium Bicarbonate, Potassium chloride, Pethedine, Fentanyl, and related vitrified solutions. The procurement encompasses 28 items with an estimated value of ₹50,000. Location data is not specified in the tender, and start/end dates are not provided. A notable condition requires OEM/imported products to have an authorized Indian presence for after-sales service, with evidence submitted. The BOQ lists 28 items but provides no quantity per item in the excerpt. The emphasis is on pharmaceutical injectables and anesthetic agents, targeting immediate availability for military medical operations. The tender indicates a single consolidated medical supply scope with emphasis on compliance and post-sale support. Unique terms include India-based after-sales support for imported products. Participants should ensure compliance with the OEM certificate requirement and prepare to submit technical compliance evidence.

Technical Specifications & Requirements

• Product names: injectables including Diclofenac 3 ml, Bupivacaine 5 mg/ml (4 ml & 20 ml инj), Lignocaine 2% (30 ml, with/without adrenaline), Ep ог, Metoclopramide 5 mg/ml 2 ml, Amikacin 250 mg/ml 2 ml, Dextrose 50% 25 ml, Dexamethasone sodium phosphate 4 mg/2 ml, Ketamine HCl 50 mg/ml 2 ml, Propofol 1% 20 ml, Thiopentone 0.5 g, Succinylcholine 50 mg/ml 2 ml, Atracurium 10 mg/ml 2.5 ml, Vecuronium 4 mg/ml 1 ml, Neostigmine 0.5 mg/ml 1 ml, Esmolol 100 mg/10 ml, Metoprolol 1 mg/ml 5 ml, Dobutamine 5 ml, Nitroglycerin 5 mg/ml 5 ml, Calcium gluconate 50 mg/Calcium 9 mg, Potassium chloride 15%, Sodium Bicarbonate 7.5%, Pethedine 50 mg 1 ml, Fentanyl 50 mcg/ml 2 ml.
• Quantities/values: Not disclosed per-item; total estimated value provided as ₹50,000.
• Standards/ Certifications: None specified in the excerpt; emphasis on post-sale service for imported items.
• Delivery/Installation: Not specified; no delivery timeline included.
• Warranty/AMC: Not specified; no warranty terms listed.
• OEM/Authorised Seller: Mandatory for imported products; must have registered office in India for after-sales service; certificate required.
• Special clauses: Indian service presence for imported medicines; 28-item scope with unified procurement approach.

Terms, Conditions & Eligibility

• OEM/Authorized Seller requirement: For imported products, must have registered Indian office for after-sales service; certificate to be submitted.
• EMD/Performance: No explicit EMD amount mentioned in the excerpt.
• Delivery timelines: Not specified; no schedule provided.
• Payment terms: Not specified in the excerpt.
• Documentation: GST, PAN, experience certificates, financial statements, EMD-related documents, OEM authorizations to be prepared; exact submission list not fully disclosed here.
• BOQ: 28 items with N/A quantities; procurement appears to be a consolidated medical injectables package.
• Compliance: Emphasis on post-sale support for imported items; adherence to Indian service availability is mandatory.
• Penalties/Warranty: Not specified in the provided data.